Thrombosis
Lower rates of access thrombosis for patients with CKD who receive daprodustat vs. EPO
PHILADELPHIA — Patients with chronic kidney disease on dialysis who received daprodustat had fewer vascular access thrombosis events compared with patients who had erythropoiesis-stimulating agents, according to data presented here.
Direct oral anticoagulants lower VTE recurrence risk in cancer-associated thrombosis
Direct oral anticoagulants for cancer-associated thrombosis appeared associated with lower risk for venous thromboembolism recurrence and major bleeds, as well as a reduction in mortality rates, among patients with cancer.
Patient-relevant bleeds ‘can be life-altering’ for many anticoagulant users
Patient-relevant bleeding negatively affected quality of life and treatment adherence among patients on anticoagulant therapy, according to results of a survey presented at International Society on Thrombosis and Hemostasis Congress.
Xarelto boosts survival for portal hypertension in cirrhosis without hike in bleeding risk
Xarelto improved portal hypertension complication-free survival in patients with cirrhosis and moderate liver dysfunction without an increase in major bleeding events, according to data presented at the EASL Congress.
Incidence of cancer-associated thrombosis remains high over time, varies with therapy
Incidence of venous thromboembolism remained high among patients with cancer even as the treatment landscape has evolved over the past 16 years, according to data published in JAMA Network Open.
Stroke, thrombosis remain rare after COVID-19 vaccination
The incidence of stroke, thrombocytopenia and thrombosis were rare in patients following COVID-19 vaccination, while all three complications were more likely in patients who received an influenza vaccination, a report found.
Milvexian granted fast track designation for prevention of thrombotic events
Bristol Myers Squibb in collaboration with Janssen Pharmaceuticals announced all three prospective antithrombotic indications for milvexian have received fast track designation from the FDA.
Active surveillance strategy significantly increases inferior vena cava filter retrieval
Active surveillance by implanting physicians appeared linked to improved retrieval of inferior vena cava filters, according to results of a retrospective cohort study.
VTE rate with abemaciclib higher in real-world setting among patients with breast cancer
Abemaciclib resulted in an approximately twofold higher venous thromboembolism rate in a real-world setting compared with clinical trials among patients with metastatic breast cancer, according to study results published in Cancer.